Volume 13 • Issue 6 • June 2019 ISSN 1814 3601

Table 1. Numbers of confirmed and total (confirmed and compatible) measles cases by month of rash onset, December 2018–May 2019, WHO Western Pacific Region

Source: Case based and aggregate data reports to the Western Pacific Regional Office by 20 June 2019

DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2019. All rights reserved

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 June 2019

No cases

<1 per million population

Legend:

*Map of Australia is from the Australian Bureau of Statistics

Figure 1. Incidence rate of measles cases with rash onset 1–31 May 2019, WHO Western Pacific Region

1.0-10.0 per million population

>10.0 per million population

No data submitted/cases pending

classification

No geographical distribution

information available

Pacific island countries and areas

No. of

confirmed

Total no.

of cases

No. of

confirmed

Total no.

of cases

No. of

confirmed

Total no.

of cases

No. of

confirmed

Total no.

of cases

No. of

confirmed

Total no.

of cases

No. of

confirmed

Total no.

of cases

Australia1 10 10 25 25 20 20 45 45 23 23 14 14

Brunei Darussalam 1 1 0 0 0 0 0 0 0 0 0 0

Cambodia 1 1 4 4 5 5 20 20 16 16 10 10

China 143 147 130 134 139 143 231 237 434 456 385 471

China, Hong Kong SAR 4 4 6 6 2 2 34 34 23 23 11 11

China, Macao SAR 1 1 2 2 2 2 29 29 6 6 2 2

Japan 12 14 134 142 134 143 93 99 92 94 100 105

Lao People's Democratic Republic 0 0 3 3 30 30 36 36 22 22 0 0

Malaysia 99 116 76 85 79 88 91 102 62 71 19 25

Mongolia 0 0 0 0 0 0 2 2 0 0 0 0

New Zealand 2 2 11 12 1 1 45 45 42 43 59 60

Papua New Guinea 0 0 0 0 0 0 0 0 0 0 0 0

Philippines2 142 720 689 3945 712 8423 532 6423 263 2924 - -

Republic of Korea 6 6 39 40 28 28 30 30 53 53 9 9

Singapore 0 0 13 13 18 18 9 9 4 6 7 9

Viet Nam 19 23 194 232 260 293 354 409 252 359 106 112

Pacific island countries and areas 0 0 0 0 0 0 0 0 0 0 0 0

Western Pacific Region 440 1045 1326 4643 1430 9196 1551 7520 1292 4096 722 828

"-" No data1 Reports only confirmed cases2 Measles burden in end 2018 is underrepresented due to lack of submission of data.

Feb MayMarJan Apr

2019

DecCountry/area

2018

Figure 2. Total (confirmed and compatible) measles cases by month of rash onset, WHO Western Pacific Region, 2014–2019* as of 20 June 2019

* Measles burden in end 2018 is underrepresented due to lack of submission of data from Philippines.

Source: Measles and rubella monthly country reports to WHO by 20 June 2019

Table 2. Status of verification of measles elimination, WHO Western Pacific Region

2

Source: Measles and rubella monthly country reports to WHO by 20 June 2019

ImportedImport-

relatedEndemic

Unknown

/ not

reported

ImportedImport-

relatedEndemic

Unknown

/ not

reported

Australia 2014 101 54 38 0 9 91.1% 127 42 60 0 25 80.3%

Brunei Darussalam 2015 1 1 0 0 0 100.0% 0 - - - - -

Cambodia 2015 3 0 0 0 3 0.0% 58 0 0 0 58 0.0%

China - 3 890 0 0 0 3 890 0.0% 1 319 0 0 0 1 319 0.0%

China, Hong Kong SAR 2016 16 7 0 0 9 43.8% 76 11 0 0 65 14.5%

China, Macao SAR 2014 3 2 0 0 1 66.7% 41 19 22 0 0 100.0%

Japan 2015 268 36 189 0 43 84.0% 552 91 313 0 148 73.2%

Lao People's Democratic Republic - 10 0 0 0 10 0.0% 91 0 0 0 91 0.0%

Malaysia - 1 861 6 0 1 375 480 74.2% 327 3 0 207 117 64.2%

Mongolia - 0 - - - - - 2 0 0 0 2 0.0%

New Zealand 2017 33 2 0 0 31 6.1% 159 9 18 0 132 17.0%

Papua New Guinea - 15 0 0 0 15 0.0% 0 - - - - -

Philippines1- 5 120 144 11 3 018 1 947 62.0% 2 196 69 0 1 634 493 77.6%

Republic of Korea 2014 19 4 4 0 11 42.1% 159 62 92 0 5 96.9%

Singapore 2018 33 8 1 0 24 27.3% 51 16 2 0 33 35.3%

Viet Nam - 913 0 0 0 913 0.0% 418 0 0 0 418 0.0%

Pacific island countries and areas - 0 - - - - - 0 - - - - -

Total 12 286 264 243 4 393 7 386 39.9% 5 576 322 507 1 841 2 906 47.9%

1 Measles burden in end 2018 is underrepresented due to lack of submission of data. Blue No measles cases

Green ≥80%

Yellow 60–79%

Red <60%

Country/areaYear

verified

2019

No. of

confirmed

cases

Source of infection % of cases

with

known

source of

infection

2018

No. of

confirmed

cases

Source of infection % of cases

with

known

source of

infection

0

5 000

10 000

15 000

20 000

25 000

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

2014 2015 2016 2017 2018 2019

Nu

mb

er

of

me

asle

s c

ase

s

China Malaysia Mongolia Papua New Guinea Philippines Viet Nam Others

Clinically

compatibleLab Epi-linked

Total

confirmed

and

clinically

compatible

Annualized

measles

incidence per

1 million pop.

Australia 74 3.1 99 4.1 81 3.3 101 4.1 25.1 NA3 0 0 0 123 4 127 12.1 0 25-May-19

Brunei Darussalam 4 9.6 1 2.4 0 0.0 1 2.3 0.4 11 0 11 0 0 0 0 0.0 0 7-Aug-16

Cambodia 0 0.0 56 3.6 10 0.6 3 0.2 16.5 556 29 469 0 58 0 58 8.4 0 9-Jun-19

China 42 864 30.7 24 839 17.7 5 993 4.3 3 975 2.8 1420.1 41 396 1 994 37 961 122 1 317 2 1 441 2.4 0 30-Apr-19

China, Hong Kong SAR 18 2.5 9 1.2 4 0.5 16 2.2 7.5 111 0 1 0 76 0 76 24.3 0 29-May-19

China, Macao SAR 0 0.0 0 0.0 2 3.2 3 4.7 0.6 108 2 65 0 41 0 41 153.2 0 6-May-19

Japan 35 0.3 163 1.3 188 1.5 279 2.2 126.9 2 288 198 1 507 31 552 0 583 11.0 0 27-May-19

Lao People's Democratic Republic 56 8.4 8 1.2 3 0.4 10 1.4 7.1 854 147 616 0 86 5 91 30.9 0 21-Apr-19

Malaysia 1 318 42.9 1 587 50.9 1 693 53.5 1 934 60.4 32.5 4 475 454 3 650 44 323 4 371 27.4 0 28-May-19

Mongolia 20 373 6843.7 28 813 9517.4 9 2.9 1 0.3 3.2 234 33 199 0 2 0 2 1.5 0 4-Mar-19

New Zealand 12 2.6 104 22.3 15 3.2 33 6.9 4.8 187 18 7 3 141 18 162 81.1 0 2-Jun-19

Papua New Guinea 53 6.7 0 0.0 7 0.8 15 1.8 8.6 2 0 2 0 0 0 0 0.0 0 6-Aug-18

Philippines4 2 003 19.7 641 6.2 2 432 23.2 18 414 172.9 108.1 33 897 11 722 341 19 638 1 214 982 21 834 484.7 35 27-Apr-19

Republic of Korea 7 0.1 18 0.4 7 0.1 19 0.4 51.3 3 492 1 3 331 1 159 0 160 7.5 0 25-May-19

Singapore 45 8.1 157 27.9 81 14.2 37 6.4 5.9 91 0 36 4 51 0 55 22.5 0 21-May-19

Viet Nam 884 9.4 368 3.9 592 6.2 1 249 12.9 97.4 4 210 2 368 371 239 1 167 0 1 406 34.6 1 14-May-19

Pacific island countries and areas5 20 6.2 6 1.8 2 0.6 0 0.0 3.4 25 0 25 0 0 0 0 0.0 0 1-May-17

Fiji 1 1.1 5 5.6 1 1.1 0 0.0 0.9 23 0 23 0 0 0 0 0.0 0 1-May-17

New Caledonia 1 3.7 1 3.6 0 0.0 0.3 2 0 2 0 0 0 0 0.0 - 10-Jan-17

Solomon Islands - - 1 1.7 0 0.0 0 0.0 0.6 - - - - - - - - - 21-Jan-16

Vanuatu 19 71.8 0 0.0 - - - - 0.3 - - - - - - - - - 23-Sep-15

Western Pacific Region 67 766 36.0 56 869 30.1 11 119 5.8 26 090 13.7 1919.2 91 937 16 966 48 592 20 082 5 310 1 015 26 407 33.0 36

1 Includes clinically compatible, laboratory confirmed and epi-linked confirmed cases Green

2 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2017 revision. Yellow

3 Australia reports confirmed cases only. Red

4 Measles burden in end 2018 is underrepresented due to lack of submission of data.

5 Classification is provisional based on laboratory data only.

Country/area

Measles

incidence

per

1 million

pop.

Total

confirmed

and

clinically

compatible1

Measles

incidence

per

1 million

pop.

2015 2019

Rash onset

of last

confirmed

measles

case

Deaths

due to

measles

Total

confirmed

and

clinically

compatible1

Measles

incidence

per

1 million

pop.

2016 2017

Total

confirmed

and

clinically

compatible1

Total

confirmed

and

clinically

compatible1

Measles

incidence

per

1 million

pop.

Population

(in millions)

2

Suspected

measles

cases

Pending

classification

Discarded

cases3

Measles cases

2018

Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2015—2019 as of 20 June 2019

3

Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2018—2019 as of 20 June 2019

2 2 2 4

Discarded non-measles

rate per

100 000 pop

Annualized discarded

non-measles rate per

100 000 pop

≥ 2 ≥ 2

Australia 3

Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data

Brunei Darussalam 5.3Not applicable

100.0% 100.0% 6.0 Not applicable 100.0% 100.0%

Cambodia 6.7 84.0% 83.2% 99.5% 6.8 80.0% 89.6% 99.5%

China 2.2 64.5% 97.7% 93.0% 6.4 64.5% 95.1% 75.8%

China, Hong Kong SAR 0.2 Not applicable 93.9% 97.0% 0.0 Not applicable 98.2% 103.6%

China, Macao SAR 4.6 Not applicable 78.1% 100.0% 24.3 Not applicable 98.1% 99.1%

Japan 1.1 6.4% Insufficient data Insufficient data 2.9 0.0% Insufficient data Insufficient data

Lao People's Democratic Republic 11.5 88.2% 89.1% 89.0% 20.9 100.0% 92.9% 93.3%

Malaysia 25.2 93.8% 91.9% 89.8% 27.0 93.8% 85.4% 92.7%

Mongolia 8.5 50.0% 98.1% 96.2% 15.1 68.2% 91.0% 92.7%

New Zealand 0.3 Insufficient data Insufficient data Insufficient data 0.4 Insufficient data Insufficient data Insufficient data

Papua New Guinea 0.9 5.0% 62.0% 91.3% 0.1 0.0% 0.0% 0.0%

Philippines 0.9 5.6% 65.4% 58.1% 0.8 11.1% 21.0% 38.2%

Republic of Korea 1.3 5.9% 78.1% 95.0% 15.6 100.0% 92.2% 100.3%

Singapore 1.3 Not applicable 67.6% 78.4% 1.5 Not applicable 81.3% 81.3%

Viet Nam 1.1 22.2% 80.7% 80.5% 0.9 22.2% 65.9% 92.0%

Pacific island countries and areas4

2.8 5.0% 45.7% 77.2% 1.8 10.0% 24.0% 84.0%

Western Pacific Region 9.8 34.8% 86.9% 84.1% 6.0 41.2% 65.5% 64.9%

≥ 80%

Second level units with

≥ 2 discarded cases per

100 000 pop

[annualized]1

Suspected cases with

adequate investigation

Suspected cases with

adequate specimens

for laboratory

confirmation 2

2018

Country/area

≥ 80% ≥ 80%

2019

Second level units with

≥ 2 discarded cases

per 100 000 pop

[annualized]1

Suspected cases with

adequate investigation

Suspected cases with

adequate specimens

for laboratory

confirmation 2

≥ 80% ≥ 80% ≥ 80%

1 This indicator is not applicable for countries which have no second-level administrative units2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases.3 Reports only confirmed cases4 Surveillance performance indicators refer to all the Pacific island countries and areas as one epidemiological block; each country is considered as second level unit

Clinically

compatible

cases

Lab Epi-linked

Australia - - - - - - - - 25.09 - - - - - - - - -

Brunei Darussalam 0 0.0 0 0.0 0 0.0 0 0.0 0.44 11 0 11 0 0 0 0 0.0 -

Cambodia 18 1.2 4 0.3 7 0.4 3 0.2 16.48 556 29 514 0 13 0 13 1.9 -

China 8 245 5.9 4 476 3.2 1 601 1.1 3 935 2.8 1 420.06 41 396 1 994 18 896 1 920 16 895 1 691 20 506 34.7 -

China, Hong Kong SAR 12 1.7 3 0.4 1 0.1 11 1.5 7.49 34 0 0 1 33 0 34 10.9 -

China, Macao SAR 2 3.3 1 1.6 0 0.0 1 1.6 0.64 108 0 58 0 50 0 50 186.9 -

Japan3 2 0.0 3 0.0 5 0.0 68 0.5 126.85 2 651 110 849 325 1 321 18 1 664 31.5 -

Lao People's Democratic Republic 24 3.6 40 5.9 12 1.7 15 2.2 7.06 854 147 702 0 5 0 5 1.7 -

Malaysia 34 1.1 68 2.2 113 3.6 180 5.6 32.45 4 528 454 4 010 0 64 0 64 4.7 -

Mongolia 28 9.4 27 8.9 13 4.2 1 0.3 3.17 234 33 200 0 1 0 1 0.8 -

New Zealand - - - - - - - - 4.79 - - - - - - - - -

Papua New Guinea 4 0.5 2 0.2 1 0.1 1 0.1 8.59 2 0 2 0 0 0 0 0.0 -

Philippines 154 1.5 165 1.6 448 4.3 129 1.2 108.11 33 897 38 33 830 0 23 6 29 0.6 -

Republic of Korea 2 0.0 3 0.1 2 0.0 0 0.00 51.34 174 1 169 0 4 0 4 0.2 -

Singapore 1 0.2 0 0.0 3 0.5 16 2.8 5.87 13 0 13 0 0 0 0 0.0 -

Viet Nam 972 10.4 350 3.7 126 1.3 102 1.1 97.43 4 210 2 357 1 793 58 2 0 60 1.5 -

Pacific island countries and areas2 1 0.3 1 0.3 4 1.2 0 0.0 3.36 25 0 25 0 0 0 0 0.0 -

Fiji 1 1.1 1 1.1 4 4.4 0 0.0 0.92 23 0 23 0 0 0 0 0.0 -

New Caledonia 0 0.0 0 0.0 0 0.0 0 0.0 0.28 2 0 2 0 0 0 0 0.0 -

Solomon Islands - - - - 0 0.0 - - 0.00 0 - - - - - - - -

Vanuatu 0 0.0 0 0.0 - - - - 0.00 0 - - - - - - - -

Western Pacific Region 9 499 5.1 5 143 2.7 2 336 1.2 4 462 2.3 1919.23 88 693 5 163 61 072 2 304 18 411 1 715 22 430 28.0 -

1 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2017 revision Green <1 confirmed measles case / 1 000 000 population

2 Classification is provisional based on laboratory data only. Yellow 1–9.9 confirmed measles case / 1 000 000 population

3 Rubella cases are cases reported as suspected measles cases that were identified as rubella laboratory confirmed cases during the investigation. This represents a small proportion of a large number of rubella cases occurring in Japan during 2018 Red >= 10 confirmed cases / 1 000 000 population

"-" No data Gray No data

2016 2018

Country/area

Total

confirmed

and

clinically

compatible

Rubella

incidence per

1 million pop.

Total

confirmed

and

clinically

compatible

Rubella

incidence per

1 million pop.

2015

Total

confirmed

and

clinically

compatible

Rubella

incidence per

1 million pop.

2019

Population

(in

millions) 1

Investigated

for rubella

Pending

classification

Discarded

cases

Total

confirmed

and

clinically

compatible

Annualized

Rubella

incidence per

1 million pop.

Congenital

rubella

syndrome

Rubella casesTotal

confirmed

and

clinically

compatible

Rubella

incidence per

1 million pop.

2017

Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2015–2019 as of 20 June 2019

5

Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2018

6

No. No. % No. %No.

received

No.

(+)

No. of

samples

tested

No. of

isolates

No. of

samples

tested

No. (+) No. No. % No. %

Australia VIDRL 73 73 61 9 9 100.0 0 0% 0 - 66.7 0 - 63 63 59 0 - - - -

Brunei Darussalam DLS 25 24 24 24 1 4.2 0 0% 0 - 100.0 0 - 0 - 0 24 0 0% 0 0%

Cambodia NIPH 1 080 1 080 1 080 940 2 0.2 0 0% 140 0 67.6 0 - 0 - 0 1 076 0 0% 0 0%

China CCDC - - - - - - - - - - 91.2 - - - - - - - - - -

China, Hong Kong SAR PHLC 531 531 430 394 14 3.6 6 2% 0 - 90.3 8 2 129 15 19 351 10 3% 4 1%

China, Macao SAR PHL 153 153 153 153 9 5.9 5 3% 0 - 100.0 0 - 9 2 9 150 11 7% 0 0%

Japan NIID 4 091 3 631 2 091 508 63 12.4 76 15% 0 - - 0 - 1 558 320 349 25 6 - 0 -

Lao People's Democratic Republic NCLE 660 660 660 660 3 0.5 12 2% 0 - 85.1 0 - 0 - 3 658 16 2% 43 7%

Malaysia NPHL 15 804 15 804 11 428 10 951 1 996 18.2 304 3% 0 - 93.3 2 180 147 0 - 2 040 7 910 331 4% 214 3%

Mongolia NCCD 244 244 244 244 0 0.0 0 0% 0 - 100.0 0 - 0 - 0 241 1 0% 0 0%

New Zealand CHL 379 379 319 89 11 12.4 1 1% 0 - 94.2 1 0 273 28 32 51 1 2% 3 6%

Papua New Guinea CPHL 91 91 93 91 13 14.3 1 1% 0 - 76.1 0 - 0 - 13 91 3 3% 8 9%

Philippines RITM 17 378 15 452 13 321 12 452 1 922 15.4 67 1% 139 18 19.2 2 297 270 2 334 1 803 3 540 11 316 91 1% 51 0%

Republic of Korea KCDC 875 875 635 551 57 10.3 48 9% 0 - 60.8 11 3 368 32 80 340 61 18% 39 11%

Singapore NPHL 628 628 610 55 5 9.1 2 4% 0 - 98.2 36 10 592 41 41 55 5 9% 9 16%

Viet Nam national lab (Northern) NIHE 1 053 1 053 1 053 1 054 575 54.6 39 4% 0 - 99.1 292 3 311 228 753 896 50 6% 38 4%

Viet Nam national lab (Southern) PI 1 187 1 187 1 187 1 187 809 68.2 1 0% 0 - 61.4 59 0 59 0 809 1 184 55 5% 43 4%

Viet Nam subnational lab (Central) PI 357 357 357 349 49 14.0 1 0% 0 - 44.3 0 - 8 2 51 352 4 1% 0 0%

Viet Nam subnational lab (Highland) IHE 162 162 162 162 74 45.7 1 1% 0 - 66.0 0 - 0 - 74 162 1 1% 1 1%

Fiji FCCDC 89 81 81 77 0 0.0 1 1% 12 0 No data 0 - 0 - 0 89 0 0% 3 3%

Total 44 860 42 465 33 989 29 950 5 612 18. 7 565 2% 291 18 75.8 4 884 435 5 704 2 534 7 872 24 971 646 3% 456 2%

"-" No data

Samples

tested for

rubella IgM

Rubella IgM (+)Rubella

IgM equivDBS samples

Total

number

of

samples

received

Total

number

of

samples

tested

Total

number

of cases

tested

Samples

tested for

measles IgM

Measles IgM (+)Measles

IgM equiv

Virus detection

Total

number of

lab

confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of

samples

with

results ≤4

days

Measles Virus

isolation/

detection

(swab, urine and

others)

Measles

Reverse

Transcription-

Polymerase Chain

Reaction

Country/area Laboratory

Measles and rubella

Measles Rubella

Serology

Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2019 as of 20 June 2019

7

No. No. % No. %No.

received

No.

(+)

No. of

samples

tested

No. of

isolates

No. of

samples

tested

No. (+) No. No. % No. %

Australia VIDRL 117 117 106 8 6 - 0 - 0 - 100.0 26 6 108 108 104 1 1 100% 0 0%

Brunei Darussalam DLS 11 11 11 11 0 - 0 - 0 - 95.8 0 - 0 - 0 11 0 0% 0 0%

Cambodia NIPH 525 525 525 525 56 10.7 1 0% 26 0 84.3 0 - 0 - 56 551 13 2% 0 0%

China CCDC - - - - - - - - - - 95.8 - - - - - - - - - -

China, Hong Kong SAR PHLC 1 989 1 989 1 195 902 47 5.2 9 1% 0 - 99.0 59 26 1 039 93 78 229 32 14% 4 2%

China, Macao SAR PHL 595 595 366 365 28 7.7 6 2% 0 - 100.0 0 - 289 52 59 364 28 8% 9 2%

Japan NIID 4 949 4 741 3 961 371 150 40.4 34 9% 0 - No data 0 - 1 703 491 553 1 069 826 77% 37 3%

Lao People's Democratic Republic NCLE 719 719 719 710 59 8.3 9 1% 0 - 90.4 0 - 0 - 59 719 8 1% 16 2%

Malaysia NPHL 8 061 8 061 5 218 4 996 421 8.4 123 2% 0 - 35.1 1 112 4 0 - 424 3 988 147 4% 73 2%

Mongolia NCCD 216 216 216 216 2 0.9 0 0% 0 - 100.0 0 - 0 - 2 215 2 1% 0 0%

New Zealand CHL 898 898 812 124 24 19.4 4 3% 0 - 96.7 0 - 774 158 158 17 2 12% 1 6%

Papua New Guinea CPHL 14 14 14 14 0 - 0 - 0 - 50.0 0 - 0 - 0 14 1 7% 0 0%

Philippines RITM 23 970 9 307 7 954 6 049 2 893 47.8 14 0% 25 2 2.1 0 - 2 361 1 782 4 403 3 179 75 2% 32 1%

Republic of Korea KCDC 5 954 5 954 3 760 2 425 149 6.1 72 3% 0 - 65.0 0 - 3 241 239 311 216 23 11% 21 10%

Singapore NPHL 251 251 246 31 5 16.1 1 3% 0 - 100.0 49 13 302 51 69 31 0 0% 1 3%

Viet Nam national lab (Northern) NIHE 1 017 1 017 988 792 601 75.9 4 1% 0 - 99.6 166 4 224 175 761 253 7 3% 0 0%

Viet Nam national lab (Southern) PI 3 214 3 214 3 213 3 199 903 28.2 11 0% 0 - 83.6 15 0 15 0 903 2 399 5 0% 5 0%

Viet Nam subnational lab (Central) PI 1 026 1 026 1 023 1 010 778 77.0 0 0% 0 - 57.2 5 0 15 10 788 830 3 0% 0 0%

Viet Nam subnational lab (Highland) IHE 1 133 1 133 1 133 1 133 1 021 90.1 7 1% 0 - 48.3 0 - 0 - 1 021 1 003 0 0% 1 0%

Fiji FCCDC 28 22 21 21 0 0.0 1 5% 0 - No data 0 - 0 - 0 21 0 0% 0 0%

Total 54 687 39 810 31 481 22 902 7 143 31. 2 296 1% 51 2 46.1 1 432 53 10 071 3 159 9 749 15 110 1 173 8% 200 1%

"-" No data

Country/area Laboratory

Measles and rubella

Measles Rubella

Serology Virus detection

Total

number of

lab

confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of

samples

with

results ≤4

days

Measles Virus

isolation/

detection

(swab, urine and

others)

Measles

Reverse

Transcription-

Polymerase Chain

Reaction

Total

number

of

samples

received

Total

number

of

samples

tested

Total

number

of cases

tested

Samples

tested for

measles IgM

Measles IgM (+)Measles

IgM equivDBS samples

Samples

tested for

rubella IgM

Rubella IgM (+)Rubella

IgM equiv

Figure 3. Measles genotype distribution of cases with rash onset in 2018 and 2019, WHO Western Pacific Region

Table 7. Measles genotype distribution of cases with rash onset in June 2018 to May 2019, WHO Western Pacific Region

8

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.

2019

Sources: Includes all cases reported to the Western Pacific Regional Office by 20 June 2019 and the Measles Nucleotide Surveillance online database (MeaNS).

B3

D4

D8

D9

D11

G3

H1

2018

B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1

Australia 1 3 1 1 1 6 3 2 1 1 1 1 3 7 4 13 11 7 4 32 3 18 4 9

Brunei Darussalam 1

Cambodia 4 2 1 9 8 6 3

China 16 2 11 9 1 1 2 2 3 1 4 2 3 1 8 1 22 10 10 6

China, Hong Kong SAR 1 1 1 2 4 1 2 29 2 19 4 1 9

China, Macao SAR 1 1 2 20 5 1

Japan 3 9 2 9 7 3 2 3 1 5 1 12 2 18 114 15 68 21 18 34 19 23 12

Lao People's Democratic Republic

Malaysia 8 13 12 6 7 8 3 7 6 8 9 13 3 10 2

Mongolia

New Zealand 3 1 3 2 7 13 2 12 1 13 2

Papua New Guinea

Philippines 11 10 9 21 24 14

Republic of Korea 2 3 1 17 15 11 16 4 20 4 50 2 7

Singapore 1 2 1 3 5 4 2 10 9 4 5 2 3

Viet Nam 22 13 1 11 32 4 9 3 21 7

Pacific island countries and areas

Country/area Sep Oct MarFebJan

2019

Nov Dec

2018

MayJun Jul Aug Apr

2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J

Australia 1

Brunei Darussalam

Cambodia

China 3 3 1 2 1 3 2 3 1 8 32 7 44 26 124 ## 136 28

China, Hong Kong SAR 1 1 3 1 3 3 8 9 1 4

China, Macao SAR 1 21 8

Japan 1 6 26 1 95 93 59 1 90 99 2 88 1

Lao People's Democratic Republic

Malaysia 2

Mongolia

New Zealand 1

Papua New Guinea

Philippines 1

Republic of Korea 2 1

Singapore 6 2

Viet Nam

Pacific island countries and areas

Country/area Jun Aug

20192018

Oct Nov MaySepJul Dec Jan Feb Mar Apr

Figure 4. Rubella genotype distribution of cases with rash onset in 2018 and 2019, WHO Western Pacific Region

Table 8. Rubella genotype distribution of cases with rash onset in June 2018 to May 2019, WHO Western Pacific Region

9

Sources: Includes all cases reported to the Western Pacific Regional Office by 20 June 2019 and the Rubella Nucleotide Surveillance online database (RubeNS).

2B

1E

2018 2019

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.

10

Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2018—2019

Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2018—2019

Expanded Programme on Immunization

Regional Office for the Western Pacific

World Health Organization

P.O. Box 2932, 1000 Manila, Philippines

Tel. No. (63 2) 5288001

Fax No. (63 2) 5211036, 5260279

Please send your comments and monthly data before the 10th of the month to:

WPROEPIdata@who.int

More detailed information available in the Regional and country profile of measles elimination

MeaNSSubmission to

WPRORubens

Submission

to WPRO

Australia 100% 92% 07 Feb 01 Mar 05 Apr 06 May 04 Jun 100% 100% 117 98 0 0

Brunei Darussalam 100% 83% 31 Jan 07 Mar 01 Apr 02 May 30 May 100% 100% 0 0 0 0

Cambodia 100% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100% 33 0 0 0

China 100% 100% 10 Feb 05 Mar 08 Apr 06 May 03 Jun 100% 100% 26 27 150 141

China, Hong Kong SAR 100% 100% 04 Feb 07 Mar 10 Apr 08 May 06 Jun 100% 100% 70 71 16 29

China, Macao SAR 100% 100% 09 Feb 08 Mar 10 Apr 10 May 10 Jun 100% 100% 28 29 0 29

Japan 100% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100% 85 342 197 281

Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100% 0 0 0 0

Malaysia 100% 75% 10 Feb 10 Mar 10 Apr 13 May 07 Jun 100% 80% 4 0 2 0

Mongolia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100% 0 0 0 0

New Zealand 100% 100% 08 Feb 07 Mar 10 Apr 10 May 10 Jun 100% 100% 58 57 1 1

Papua New Guinea 100% 92% - 12 Mar 08 Apr 09 May 07 Jun 80% 60% 0 0 0 0

Philippines 100% 92% 08 Feb 12 Mar 10 Apr - 10 Jun 80% 60% 0 0 0 0

Republic of Korea 100% 100% 09 Feb 08 Mar 10 Apr 10 May 07 Jun 100% 100% 0 156 0 3

Singapore 100% 100% 08 Feb 08 Mar 10 Apr 09 May 06 Jun 100% 100% 41 44 0 0

Viet Nam national lab (Northern) 100% 100% 01 Feb 05 Mar 11 Apr 09 May 06 Jun 100% 100% 32 11 0 0

Viet Nam national lab (Southern) 100% 100% 10 Feb 08 Mar 08 Apr 09 May 06 Jun 100% 100% 8 0 0 0

Viet Nam subnational lab (Central) 100% 100% 10 Feb 05 Mar 11 Apr 09 May 06 Jun 100% 100% 0 0 0 0

Viet Nam subnational lab (Highland) 100% 100% 10 Feb 05 Mar 11 Apr 09 May 06 Jun 100% 100% 0 0 0 0

Fiji 100% 83% 14 Feb 18 Mar 15 Apr 15 May 14 Jun 100% 80% 0 0 0 0

Completeness 100% 95% 100% 100% 95% 100% 78%

Timeliness 95% 95% 85% 100% 90% 95% 94%

1 National measles laboratory monthly reports from May 2019.

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

3 National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.

502 835 366 484

Completeness 2 Timeliness 3

Genotype results by source of data

Measles Rubella

2019 1

Jan Feb Mar Apr MayCompleteness 2 Timeliness 3

2018 1

Country/area

Jan Feb Mar Apr May

Australia 100% 92% 08 Feb 08 Mar 10 Apr 10 May 07 Jun 100% 100%

Brunei Darussalam 100% 100% 06 Feb 07 Mar 02 Apr 06 May 04 Jun 100% 100%

Cambodia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100%

China 100% 83% 18 Feb 11 Mar 15 Apr 29 May 11 Jun 100% 60%

China, Hong Kong SAR 100% 100% 08 Feb 08 Mar - 08 May 10 Jun 80% 80%

China, Macao SAR 100% 100% 08 Feb 08 Mar 10 Apr 09 May 10 Jun 100% 100%

Japan 100% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100%

Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100%

Malaysia 100% 100% 10 Feb 10 Mar 10 Apr 09 May 10 Jun 100% 100%

Mongolia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 100% 100%

New Zealand 100% 100% 08 Feb 07 Mar 10 Apr 10 May 10 Jun 100% 100%

Papua New Guinea 58% 17% - 28 Mar - 10 May 11 Jun 60% 20%

Philippines 83% 8% 26 Feb - - 23 May - 40% 0%

Republic of Korea 100% 67% - 13 Mar 14 Apr 21 May 11 Jun 80% 0%

Singapore 100% 100% 08 Feb 08 Mar 10 Apr 09 May 06 Jun 100% 100%

Viet Nam 100% 92% - 08 Mar 07 Apr 07 May 10 Jun 80% 80%

Pacific island countries and areas 100% 92% 14 Feb 18 Mar 15 Apr 15 May 14 Jun 100% 80%

Completeness 97% 82% 94% 82% 100% 94% 72%

Timeliness 85% 71% 76% 76% 82% 82% 78%

1 National measles surveillance monthly reports from May 2019. Legend: black = timely report; red = untimely report

Completeness 2 Timeliness 3

2018 1

Completeness 2 Timeliness 3

3 Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or

the next working day) of the following month.

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

Country2019 1